Stories

FDA wants brand and generic drug makers to get along

Two sets of test tubes sit in a pharmaceutical lab.
The FDA issued new generic drug guidance. Photo: Saul Loeb/AFP via Getty Images

The Food and Drug Administration is rolling out official guidance on how it expects pharmaceutical companies to behave when generic drugs are ready to enter the market — namely by all parties using a shared safety protocol.

The bottom line: The guidance is not legally enforceable. But FDA Commissioner Scott Gottlieb said the policies should discourage companies that make brand-name drugs from using a drug safety system to "block generic entry and help end some of the tactics that can delay access."